Physician profile
Harry J Smith
NPI 1861433542
$9,817.71
in general payments reported to CMS, 2019-2025
70 companies · $1,883 in 2025
The $1,883 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,948 · 2020: $528 · 2021: $337 · 2022: $1,636 · 2023: $1,687 · 2024: $1,798 · 2025: $1,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,807 · Education: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,807.38 |
| Education | $561.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $767.24 | 2019-2025 | Erleada, Rybrevant, Darzalex |
| Pfizer INC. | $565.33 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $538.26 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Seagen INC. | $491.12 | 2021-2025 | Padcev, Tukysa |
| E.R. Squibb & Sons, L.L.C. | $458.58 | 2019-2025 | Opdivo, Opdualag |
| Incyte Corporation | $436.39 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Glaxosmithkline, LLC. | $411.18 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Astellas Pharma US INC | $370.97 | 2019-2025 | Xtandi, Padcev |
| Genzyme Corporation | $354.35 | 2019-2025 | |
| Genentech USA, INC. | $337.73 | 2019-2024 | Tecentriq, Lunsumio, Alecensa |
| Celgene Corporation | $316.94 | 2019-2025 | Pomalyst, Reblozyl |
| Daiichi Sankyo INC. | $252.48 | 2019-2025 | Enhertu |
| Lilly USA, LLC | $230.39 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Astrazeneca Pharmaceuticals LP | $227.27 | 2019-2025 | Imfinzi, Calquence, Tagrisso |
| Novartis Pharmaceuticals Corporation | $209.54 | 2022-2025 |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $206.76 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Puma Biotechnology, INC. | $186.99 | 2019-2025 | Nerlynx |
| Eisai INC. | $183.43 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.31 | 2019-2023 | Gilotrif |
| Takeda Pharmaceuticals U.S.A., INC. | $149.77 | 2019-2024 | Ninlaro, Alunbrig, Fruzaqla |
| Jazz Pharmaceuticals INC. | $149.49 | 2019-2025 | Zepzelca |
| Clovis Oncology, INC. | $146.18 | 2019-2022 | |
| Sobi, INC | $140.03 | 2023-2025 | Doptelet, Vonjo |
| Exelixis INC. | $133.68 | 2019-2024 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $127.36 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $120.07 | 2022-2025 | Fotivda |
| Pharmacyclics LLC, An Abbvie Company | $118.11 | 2022-2023 | Imbruvica, Epkinly |
| Amgen INC. | $113.56 | 2019-2023 | Blincyto, Kyprolis |
| Sun Pharmaceutical Industries INC. | $110.13 | 2019-2023 | Yonsa, Odomzo |
| Beigene USA, INC. | $105.93 | 2021-2024 | Brukinsa |
| Abbvie INC. | $92.30 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $91.78 | 2019-2024 | Ultomiris |
| Tersera Therapeutics LLC | $86.14 | 2022-2025 | Zoladex |
| Immunocore Limited | $77.54 | 2024-2025 | Kimmtrak |
| Stemline Therapeutics INC. | $76.85 | 2023-2025 | Orserdu |
| Janssen Pharmaceuticals, INC | $75.38 | 2019-2024 | Rybrevant, Xarelto |
| Gilead Sciences, INC. | $73.14 | 2021-2025 | Trodelvy |
| Deciphera Pharmaceuticals INC. | $73.04 | 2021-2025 | Tgct, Qinlock |
| Regeneron Healthcare Solutions, INC. | $70.91 | 2023-2025 | Libtayo |
| Emd Serono, INC. | $68.30 | 2022-2025 | |
| Array Biopharma INC | $64.71 | 2019-2025 | Braftovi, Mektovi, Tukysa |
| Genmab U.S., INC. | $57.57 | 2023-2025 | Epkinly, Tivdak |
| Karyopharm Therapeutics INC. | $56.54 | 2022-2024 | Xpovio |
| Taiho Oncology, INC. | $52.34 | 2019-2023 | |
| Pharmacosmos Therapeutics INC. | $48.50 | 2024-2025 | Monoferric |
| Mylan Institutional INC. | $42.57 | 2021-2022 | |
| Agios Pharmaceuticals, INC. | $39.62 | 2024 | Pyrukynd |
| Blueprint Medicines Corporation | $39.20 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $37.40 | 2020-2023 | Givlaari |
| Kite Pharma, INC. | $33.16 | 2025 | Yescarta |
| Legend Biotech USA INC. | $32.49 | 2025 | Carvykti |
| Mirati Therapeutics, INC. | $32.19 | 2023-2024 | Krazati |
| Springworks Therapeutics, INC. | $27.65 | 2025 | Ogsiveo |
| Macrogenics, INC. | $27.53 | 2023 | |
| Dendreon Pharmaceuticals LLC | $27.33 | 2019 | |
| Beone Medicines USA, INC. | $27.07 | 2025 | Brukinsa |
| Boston Scientific Corporation | $24.81 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Pharmaessentia USA Corporation | $24.03 | 2022 | |
| Apellis Pharmaceuticals, INC. | $23.83 | 2022 | |
| Spectrum Pharmaceuticals INC. | $22.91 | 2025 | Rolvedon |
| Cti Biopharma Corp. | $22.67 | 2023 | Vonjo |
| Kyowa Kirin, INC. | $19.70 | 2022 | |
| Morphosys, US INC. | $18.52 | 2022 | |
| Geron Corporation | $17.84 | 2025 | Rytelo |
| Tolmar, INC. | $17.70 | 2024 | |
| Pharming Healthcare, INC. | $17.62 | 2024 | Ruconest |
| Ipsen Biopharmaceuticals, INC | $17.46 | 2025 | Onivyde |
| Tactile Systems Technology INC | $16.75 | 2024 | Flexitouch Plus, Entre Plus |
| Amag Pharmaceuticals, INC. | $15.09 | 2022 | |
| Dova Pharmaceuticals | $13.96 | 2019 |
Drugs and devices associated with these payments
Erleada $328Xtandi $239Keytruda $233Ojjaara $189Enhertu $156Talzenna $148Lenvima $147Sarclisa $135Padcev $133Opdivo $131Tavalisse $130Rezlidhia $130Tukysa $127Jakafi $121Imbruvica $116Verzenio $107Jaypirca $107Ibrance $103Orgovyx $103Rybrevant $97.42Kisqali $91.96Epkinly $91.43Doptelet $89.00Zepzelca $85.65Inlyta $81.39Nubeqa $80.94Monjuvi $80.78Kimmtrak $77.54Orserdu $76.85Welireg $72.21Fotivda $71.24Libtayo $70.91Brukinsa $70.18Pomalyst $66.06Zoladex $63.83Lynparza $61.81Stivarga $57.51Jevtana $57.34Reblozyl $56.44Darzalex $52.44Imfinzi $48.52Monoferric $48.50Ultomiris $48.33Vonjo $47.48Braftovi $45.72Mektovi $45.72Akeega $43.83Tecentriq $43.13Lunsumio $41.89Xofigo $39.67Zejula $37.35Jemperli $37.35Xpovio $36.98Adcetris $36.65Calquence $34.93Trodelvy $33.40Yescarta $33.16Carvykti $32.49Krazati $32.19Blenrep $31.15Nerlynx $30.43Pluvicto $30.40Ninlaro $29.91Comirnaty $28.06Ogsiveo $27.65Scemblix $27.54Margenza $27.53Odomzo $26.43Yonsa $26.43Synagis $26.22Tgct $25.69Qinlock $25.69Therasphere Y90 Glass Microspheres 10 Gbq $24.81Elitek $24.42Rolvedon $22.91Tecvayli $22.57Talvey $22.57Pemazyre $22.27Alunbrig $22.07Gavreto $21.69Cabometyx $21.64Opdualag $20.88Pyrukynd $20.86Enjaymo $20.85Vitrakvi $19.89Gilotrif $19.79Tivdak $19.77Alecensa $19.66Lonsurf $19.64Inqovi $19.64Retevmo $19.49Niktimvo $19.09Tagrisso $18.77Rytelo $17.84Eligard $17.70Ruconest $17.62Onivyde $17.46Flexitouch Plus $16.75Entre Plus $16.75Promacta $16.29
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.